Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.87
HNSN's Cash to Debt is ranked lower than
59% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. HNSN: 0.87 )
Ranked among companies with meaningful Cash to Debt only.
HNSN' s Cash to Debt Range Over the Past 10 Years
Min: 0.71  Med: 4.46 Max: No Debt
Current: 0.87
Equity to Asset 0.24
HNSN's Equity to Asset is ranked lower than
91% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.62 vs. HNSN: 0.24 )
Ranked among companies with meaningful Equity to Asset only.
HNSN' s Equity to Asset Range Over the Past 10 Years
Min: -0.06  Med: 0.51 Max: 0.9
Current: 0.24
-0.06
0.9
F-Score: 3
Z-Score: -12.37
M-Score: -2.61
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -225.40
HNSN's Operating margin (%) is ranked lower than
92% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.54 vs. HNSN: -225.40 )
Ranked among companies with meaningful Operating margin (%) only.
HNSN' s Operating margin (%) Range Over the Past 10 Years
Min: -531.5  Med: -234.22 Max: -70.79
Current: -225.4
-531.5
-70.79
Net-margin (%) -272.41
HNSN's Net-margin (%) is ranked lower than
92% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. HNSN: -272.41 )
Ranked among companies with meaningful Net-margin (%) only.
HNSN' s Net-margin (%) Range Over the Past 10 Years
Min: -499.96  Med: -241.52 Max: -75.52
Current: -272.41
-499.96
-75.52
ROE (%) -585.07
HNSN's ROE (%) is ranked lower than
98% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. HNSN: -585.07 )
Ranked among companies with meaningful ROE (%) only.
HNSN' s ROE (%) Range Over the Past 10 Years
Min: -440.22  Med: -117.46 Max: -52.02
Current: -585.07
-440.22
-52.02
ROA (%) -74.01
HNSN's ROA (%) is ranked lower than
92% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.51 vs. HNSN: -74.01 )
Ranked among companies with meaningful ROA (%) only.
HNSN' s ROA (%) Range Over the Past 10 Years
Min: -94.48  Med: -71.91 Max: -24.81
Current: -74.01
-94.48
-24.81
ROC (Joel Greenblatt) (%) -464.34
HNSN's ROC (Joel Greenblatt) (%) is ranked lower than
91% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.13 vs. HNSN: -464.34 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HNSN' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -2411.13  Med: -419.62 Max: -156.29
Current: -464.34
-2411.13
-156.29
Revenue Growth (3Y)(%) -25.40
HNSN's Revenue Growth (3Y)(%) is ranked lower than
92% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. HNSN: -25.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HNSN' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -25.50 Max: -10
Current: -25.4
EBITDA Growth (3Y)(%) 20.10
HNSN's EBITDA Growth (3Y)(%) is ranked higher than
78% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.60 vs. HNSN: 20.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HNSN' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -53.5  Med: -35.80 Max: 60
Current: 20.1
-53.5
60
EPS Growth (3Y)(%) 15.30
HNSN's EPS Growth (3Y)(%) is ranked higher than
69% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.40 vs. HNSN: 15.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HNSN' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -50  Med: -36.60 Max: 60
Current: 15.3
-50
60
» HNSN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

HNSN Guru Trades in

HNSN Guru Trades in

HNSN Guru Trades in

Q2 2014

HNSN Guru Trades in Q2 2014

George Soros Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with HNSN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 4.37
HNSN's P/B is ranked lower than
65% of the 254 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. HNSN: 4.37 )
Ranked among companies with meaningful P/B only.
HNSN' s P/B Range Over the Past 10 Years
Min: 1.56  Med: 6.19 Max: 30.13
Current: 4.37
1.56
30.13
P/S 2.65
HNSN's P/S is ranked higher than
53% of the 252 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.94 vs. HNSN: 2.65 )
Ranked among companies with meaningful P/S only.
HNSN' s P/S Range Over the Past 10 Years
Min: 1.23  Med: 6.52 Max: 218.94
Current: 2.65
1.23
218.94
Current Ratio 7.04
HNSN's Current Ratio is ranked higher than
89% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.66 vs. HNSN: 7.04 )
Ranked among companies with meaningful Current Ratio only.
HNSN' s Current Ratio Range Over the Past 10 Years
Min: 1.45  Med: 4.03 Max: 26.06
Current: 7.04
1.45
26.06
Quick Ratio 5.36
HNSN's Quick Ratio is ranked higher than
87% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. HNSN: 5.36 )
Ranked among companies with meaningful Quick Ratio only.
HNSN' s Quick Ratio Range Over the Past 10 Years
Min: 1.04  Med: 3.40 Max: 26.06
Current: 5.36
1.04
26.06
Days Inventory 263.83
HNSN's Days Inventory is ranked lower than
87% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 130.74 vs. HNSN: 263.83 )
Ranked among companies with meaningful Days Inventory only.
HNSN' s Days Inventory Range Over the Past 10 Years
Min: 65.35  Med: 152.58 Max: 288.85
Current: 263.83
65.35
288.85
Days Sales Outstanding 71.33
HNSN's Days Sales Outstanding is ranked lower than
62% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 64.59 vs. HNSN: 71.33 )
Ranked among companies with meaningful Days Sales Outstanding only.
HNSN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 90.6  Med: 109.14 Max: 147.99
Current: 71.33
90.6
147.99
Days Payable 22.14
HNSN's Days Payable is ranked lower than
90% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.63 vs. HNSN: 22.14 )
Ranked among companies with meaningful Days Payable only.
HNSN' s Days Payable Range Over the Past 10 Years
Min: 46.75  Med: 70.32 Max: 118.07
Current: 22.14
46.75
118.07

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 12.74
HNSN's Price/Net Current Asset Value is ranked lower than
70% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.42 vs. HNSN: 12.74 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
HNSN' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 2.94  Med: 7.70 Max: 45.61
Current: 12.74
2.94
45.61
Price/Tangible Book 4.31
HNSN's Price/Tangible Book is ranked higher than
51% of the 232 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.39 vs. HNSN: 4.31 )
Ranked among companies with meaningful Price/Tangible Book only.
HNSN' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.91  Med: 5.73 Max: 24.25
Current: 4.31
1.91
24.25
Price/Median PS Value 0.38
HNSN's Price/Median PS Value is ranked higher than
92% of the 253 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. HNSN: 0.38 )
Ranked among companies with meaningful Price/Median PS Value only.
HNSN' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.47  Med: 1.03 Max: 25.63
Current: 0.38
0.47
25.63
Earnings Yield (Greenblatt) (%) -69.91
HNSN's Earnings Yield (Greenblatt) (%) is ranked lower than
97% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. HNSN: -69.91 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HNSN' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -107.19  Med: 0.00 Max: 0
Current: -69.91
-107.19
0

More Statistics

Revenue(Mil) $17
EPS $ -4.44
Beta-0.20
Short Percentage of Float13.71%
52-Week Range $1.28 - 12.30
Shares Outstanding(Mil)18.87

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:H9M.Germany,
Hansen Medical Inc, formerly known as AutoCath Inc, was incorporated in Delaware in 2002. The Company completed its initial public offering on February 28, 2014. The Company develops, manufactures and sells medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System, Magellan Robotic System, Artisan catheter, Lynx catheter, Magellan Robotic Catheter, and CoHesion 3D Visualization Module. Sensei Robotic Catheter System, or Sensei system, is designed to allow physicians to navigate flexible catheters with solid stability and control in interventional procedures within the atrial heart chambers. This system enables physicians to direct the movements of a robotic catheter like the Company's Artisan Control Catheter and Artisan Extend Control Catheter, or Artisan catheters, and Lynx Robotic Ablation Catheter, or Lynx catheter, to an anatomical location. The Sensei system is comprised of two modules: a physician control console and a patient-side module that can be connected to procedure tables. The control console can be located inside the Electro-Physiology Laboratory, or EP lab, and close to the patient or outside the EP lab in a separate location shielded from radiation. The Company's Magellan Robotic System is a peripheral vascular interventional platform that, used in combination with the Magellan Robotic Catheters, has the potential to provide endovascular specialists with vessel navigation, catheter stability during the manual delivery and placement of therapeutic devices, reduced procedural radiation exposure and fatigue, and precise robotic control of distal catheter tips. Magellan Robotic System is comprised of two modules: a physician control console and a patient-side robotic arm that can be connected to procedure tables. The Artisan catheter is a disposable catheter and guide catheter assembly that consists of a telescoping set of control catheters that are integrated to provide the desired motion of the tip of a diagnostic or therapeutic catheter that is inserted through the center lumen of the Artisan catheter. This is designed to accurately control the movement of a third party catheter chosen by the physician. CoHesion 3D Visualization Module, or CoHesion Module, is a software interface between Sensei system and the St. Jude Medical EnSite System for EP procedures. It is designed to provide physicians with 3D visualization to augment their ability to move a catheter throughout the atria, as well as increase control over placement of the catheter in specific locations. The Company markets, sells and supports its products in the United States through a direct sales force of regional sales employees, supported by clinical account managers who provide training, clinical support and other services to customers. Outside the United States, in the European Union, it uses a combination of a direct sales for
» More Articles for HNSN

Headlines

Articles On GuruFocus.com
Insiders' New Buys : MAC, SPB, PDVW, HNSN, THRX, RSG, CVX May 18 2015 
5-year lows: Layne Christensen Co, Hansen Medical Inc, API Technologies Corp, and Female Health Co. Jul 27 2014 
HANSEN MEDICAL, INC. Reports Operating Results (10-Q) May 10 2010 
Weekly CEO Buys Highlight: Hansen Medical Inc., Trans World Entertainment Corp, Winmark Corp, ZEP IN Apr 24 2010 
HANSEN MEDICAL, INC. Reports Operating Results (10-Q/A) Nov 16 2009 
HANSEN MEDICAL, INC. Reports Operating Results (10-Q) Aug 06 2009 
Weekly CEO Buy Highlights: Huntington Bancshares, Brown & Brown Inc, The Greenbrier Companies, Prosp Apr 25 2009 

More From Other Websites
Why These 5 Stocks Are Climbing Higher As The Market Sinks Feb 02 2016
4 Stocks That are Making Big Moves Early Today Feb 02 2016
Hansen Medical(R) Announces FDA Clearance of the Magellan(TM) Robotic Catheter eKit Feb 02 2016
Hansen Medical(R) Announces Latest Publication in the Journal of Interventional Cardiac... Feb 01 2016
HNSN: Revolutionizing Physicians’ Capabilities With Robotics! Jan 28 2016
The Life Sciences Report Interviews Alan Leong of BioWatch News Jan 22 2016
HANSEN MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events,... Jan 14 2016
[$$] Hansen Medical to Consider Strategic Options Jan 14 2016
Hansen Medical Announces Exploration of Strategic Alternatives Jan 14 2016
Hansen Medical Provides Corporate Update of Key Near-Term Clinical, Regulatory and Commercial Events Jan 14 2016
Hansen Medical Provides Corporate Update of Key Near-Term Clinical, Regulatory and Commercial Events Jan 14 2016
Hansen Medical Announces Exploration of Strategic Alternatives Jan 14 2016
HANSEN MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Dec 21 2015
Hansen Medical Completes Sensei Commercial Transaction in Cooperation With Medtronic Dec 21 2015
Hansen Medical Completes Sensei Commercial Transaction in Cooperation With Medtronic Dec 21 2015
Hansen Medical, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 16 2015
Hansen Medical, Inc. (HNSN): Hedge Funds Are Snapping Up Dec 10 2015
Hansen Medical Elevates Status of Robotic Microcatheter Development Dec 10 2015
HANSEN MEDICAL INC Financials Dec 08 2015
Hansen Medical Announces Advancement in 3D Robotic Catheter Tracking at Pumps and Pipes Meeting Dec 07 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK